Phenylephrine IV Bags Recalled for Lack of Sterility Assurance
CMC Enterprise Pharmacy is recalling 215 bags of Phenylephrine 40 mg in 0.9% Sodium Chloride due to a lack of sterility assurance. The product was distributed in North Carolina.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects, are rated as Severe (4). While no specific injuries are reported in the text, the lack of sterility assurance in an IV product presents a significant risk of infection, aligning with the Severe classification for Class II drug recalls.
Plain-English summary
CMC Enterprise Pharmacy is recalling 215 bags of Phenylephrine 40 mg in 0.9% Sodium Chloride 250 mL bags (160 mcg/mL). The recall is being conducted due to a lack of sterility assurance for the product.
The affected product was distributed in North Carolina. The specific lots involved are ED041912 (Exp. 4/13/2019), ED051912 (Exp. 4/14/2019), ED081912 (Exp. 4/17/2019), ED091911 (Exp. 4/18/2019), ED101912 (Exp. 4/19/2019), and ED111910 (Exp. 4/20/2019).
Healthcare providers and patients should stop using the affected product and contact the recalling firm for further instructions.
The recalled product
- Product
- Phenylephrine 40 mg in 0.9% Sodium Chloride 250 mL bag, 160 mcg/mL, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.
- Manufacturer
- CMC Enterprise Pharmacy
- Category
- Drug — IV Solution
- Hazard
- Affected units
- 215
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: ED041912 Exp. 4/13/2019
- ED051912 Exp. 4/14/2019
- ED081912 Exp. 4/17/2019
- ED091911 Exp. 4/18/2019
- ED101912 Exp. 4/19/2019
- ED111910 Exp. 4/20/2019
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by CMC Enterprise Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · CMC Enterprise Pharmacy
See all →- SevereCMC Enterprise Pharmacy Recalls CeFAZolin Due to Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Oxytocin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
- SevereDiltiazem 250 mg IV Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-05-01
- SevereCMC Enterprise Pharmacy Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2019-05-01
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereSCA Pharmaceuticals Recalls Phenylephrine IV Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-02
- SevereSCA Pharmaceuticals Recalls Phenylephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2018-07-11
- HighPhenylephrine IV Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-09-06
- SevereSCA Pharmaceuticals Recalls Phenylephrine HCL Bags Due to Sterility Concerns
FDA (Drugs) · 2018-07-11
- HighPharmaceutical Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-04-03
- SevereSCA Pharmaceuticals Recalls Phenylephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-02